These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7672162)

  • 1. A case of severe ovarian hyperstimulation in a healthy oocyte donor.
    Halme J; Toma SK; Talbert LM
    Fertil Steril; 1995 Oct; 64(4):857-9. PubMed ID: 7672162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors.
    Sauer MV; Paulson RJ; Lobo RA
    Int J Gynaecol Obstet; 1996 Mar; 52(3):259-62. PubMed ID: 8775679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of both serious and minor complications in young women undergoing oocyte donation.
    Maxwell KN; Cholst IN; Rosenwaks Z
    Fertil Steril; 2008 Dec; 90(6):2165-71. PubMed ID: 18249368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?
    Lewit N; Kol S; Ronen N; Itskovitz-Eldor J
    Fertil Steril; 1996 Oct; 66(4):654-6. PubMed ID: 8816633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
    Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
    Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation syndrome (OHSS): how much do we really know about it?
    Tsirigotis M; Craft I
    Eur J Obstet Gynecol Reprod Biol; 1994 Jun; 55(3):151-5. PubMed ID: 7958157
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2002; (2):CD001302. PubMed ID: 12076404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in vitro fertilization and embryo transfer.
    Mukherjee T; Copperman AB; Sandler B; Bustillo M; Grunfeld L
    Fertil Steril; 1995 Sep; 64(3):641-3. PubMed ID: 7641923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study.
    Bellver J; Muñoz EA; Ballesteros A; Soares SR; Bosch E; Simón C; Pellicer A; Remohí J
    Hum Reprod; 2003 Nov; 18(11):2283-8. PubMed ID: 14585874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conundrum of oocyte donation, human research, OHSS, and ethics.
    Stein AL
    Am J Bioeth; 2011 Sep; 11(9):35-7. PubMed ID: 21877972
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report.
    Abramov Y; Fatum M; Abrahamov D; Schenker JG
    Fertil Steril; 2001 Jun; 75(6):1228-30. PubMed ID: 11384657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2000; (2):CD001302. PubMed ID: 10796765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research.
    Jayaprakasan K; Herbert M; Moody E; Stewart JA; Murdoch AP
    Hum Fertil (Camb); 2007 Sep; 10(3):183-7. PubMed ID: 17786651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.
    Shoham Z; Weissman A; Barash A; Borenstein R; Schachter M; Insler V
    Fertil Steril; 1994 Jul; 62(1):137-42. PubMed ID: 8005278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human albumin is effective in prevention of severe OHSS.
    Al-Inany HG
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):878-82. PubMed ID: 11580730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Yang JH; Chen SU; Ho HN; Yang YS
    Fertil Steril; 1997 Aug; 68(2):287-91. PubMed ID: 9240258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures.
    Rizk B; Smitz J
    Hum Reprod; 1992 Mar; 7(3):320-7. PubMed ID: 1587936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
    Hernández ER; Gómez-Palomares JL; Ricciarelli E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
    Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
    PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.